140 related articles for article (PubMed ID: 37003892)
1. Brain iron deposition is positively correlated with cognitive impairment in patients with chronic cerebral hypoperfusion: a MRI susceptibility mapping study.
Yu JJ; Li C; Qian ZM; Liu Y
Clin Radiol; 2023 Aug; 78(8):601-607. PubMed ID: 37003892
[TBL] [Abstract][Full Text] [Related]
2. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension.
Qin Z; Wu W; Liu D; Zheng C; Kang J; Zhou H; Meng X; Haacke EM; Wang L
J Magn Reson Imaging; 2022 Aug; 56(2):508-515. PubMed ID: 34989062
[TBL] [Abstract][Full Text] [Related]
4. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
[TBL] [Abstract][Full Text] [Related]
5. Brain iron deposition in primary insomnia-An in vivo susceptibility-weighted imaging study.
Chen L; Wei X; Liu C; Li C; Zhou Z
Brain Behav; 2019 Jan; 9(1):e01138. PubMed ID: 30548431
[TBL] [Abstract][Full Text] [Related]
6. Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis.
Zhao Y; Qu H; Wang W; Liu J; Pan Y; Li Z; Xu G; Hu C
Eur Neurol; 2022; 85(4):280-290. PubMed ID: 35313305
[TBL] [Abstract][Full Text] [Related]
7. Monitoring mild cognitive impairment of workers exposed to occupational aluminium based on quantitative susceptibility mapping.
Zhang ZY; Jiang HR; Sun XR; Wang XC; Niu Q; Meng HX; Du JF; Yang GQ; Zhang H; Tan Y
Clin Radiol; 2022 Nov; 77(11):840-847. PubMed ID: 35817609
[TBL] [Abstract][Full Text] [Related]
8. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
9. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
Uchida Y; Kan H; Sakurai K; Arai N; Kato D; Kawashima S; Ueki Y; Matsukawa N
Mov Disord; 2019 Aug; 34(8):1164-1173. PubMed ID: 31091347
[TBL] [Abstract][Full Text] [Related]
10. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
[TBL] [Abstract][Full Text] [Related]
11. R2* relaxometry analysis for mapping of white matter alteration in Parkinson's disease with mild cognitive impairment.
Kan H; Uchida Y; Ueki Y; Arai N; Tsubokura S; Kunitomo H; Kasai H; Aoyama K; Matsukawa N; Shibamoto Y
Neuroimage Clin; 2022; 33():102938. PubMed ID: 34998126
[TBL] [Abstract][Full Text] [Related]
12. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
13. Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment.
Gao L; Jiang Z; Cai Z; Cai M; Zhang Q; Ma Y; Li G; Zhao F; Ma Q
Mol Med Rep; 2017 Dec; 16(6):8209-8215. PubMed ID: 28990041
[TBL] [Abstract][Full Text] [Related]
14. Iron deposition in the precuneus is correlated with mild cognitive impairment in patients with cerebral microbleeds: A quantitative susceptibility mapping study.
Tu J; Yan J; Liu J; Liu D; Wang X; Gao F
Front Neurosci; 2022; 16():944709. PubMed ID: 36003962
[TBL] [Abstract][Full Text] [Related]
15. Altered brain iron deposition in patients with minimal hepatic encephalopathy: an MRI quantitative susceptibility mapping study.
Wang M; Yang X; Liu D; Dang P; Huang X; Zheng J; Ding F; Ding X; Wang X
Clin Radiol; 2024 Mar; 79(3):e369-e375. PubMed ID: 38071103
[TBL] [Abstract][Full Text] [Related]
16. Cortical Iron Accumulation as an Imaging Marker for Neurodegeneration in Clinical Cognitive Impairment Spectrum: A Quantitative Susceptibility Mapping Study.
Kim HW; Lee S; Yang JH; Moon Y; Lee J; Moon WJ
Korean J Radiol; 2023 Nov; 24(11):1131-1141. PubMed ID: 37899522
[TBL] [Abstract][Full Text] [Related]
17. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Microbleeds Are Associated With Increased Brain Iron and Cognitive Impairment in Patients With Cerebral Small Vessel Disease: A Quantitative Susceptibility Mapping Study.
Li J; Nguyen TD; Zhang Q; Guo L; Wang Y
J Magn Reson Imaging; 2022 Sep; 56(3):904-914. PubMed ID: 35099829
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker.
Sun Y; Ge X; Han X; Cao W; Wang Y; Ding W; Cao M; Zhang Y; Xu Q; Zhou Y; Xu J
Front Aging Neurosci; 2017; 9():81. PubMed ID: 28424610
[TBL] [Abstract][Full Text] [Related]
20. Associations of cortical iron accumulation with cognition and cerebral atrophy in Alzheimer's disease.
Yang A; Du L; Gao W; Liu B; Chen Y; Wang Y; Liu X; Lv K; Zhang W; Xia H; Wu K; Ma G
Quant Imaging Med Surg; 2022 Sep; 12(9):4570-4586. PubMed ID: 36060596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
